Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098497 · ClinicalTrials.gov registry record · Phase 1

Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3

A Phase 1 study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target

NCT04098497 is a Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098497, a Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target

Study Summary

This study is a 6-week micro-randomized trial investigating the feasibility of a mobile health platform. Its long-term objective is to develop a mobile health platform for the translation of a psychosocial intervention for bipolar disorder (BP) into an effective and evidence-based adaptive intervention. In this aim of the study, investigators will evaluate how individuals with BP respond to a microintervention based in acceptance and commitment therapy (ACT) that is delivered with a mobile app.

Interventions

  • BEHAVIORAL Mobile intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-09-13
Est. Completion 2020-10-21
Phase Phase 1

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT04098497

The ClinicalTrials.gov registry entry for NCT04098497 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mobile intervention is the first listed.

NCT04098497 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04098497 about?

NCT04098497 is a clinical study titled "Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3". This study is a 6-week micro-randomized trial investigating the feasibility of a mobile health platform. Its long-term objective is to develop a mobile health platform for the translation of a psychosocial intervention for bipolar disorder (BP) into an effective and evidence-based adaptive intervent...

What is the current status of trial NCT04098497?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2019-09-13. Estimated completion is 2020-10-21.

What interventions are being tested in trial NCT04098497?

The interventions under investigation include: Mobile intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04098497?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.